[PDF][PDF] Use of valsartan in post-myocardial infarction and heart failure patients
PP Liu, A Maggioni, EJ Velazquez - J Renin Angiotensin …, 2006 - researchgate.net
… Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results
from the Valsartan Heart Failure Trial (Val-HeFT). Am …
from the Valsartan Heart Failure Trial (Val-HeFT). Am …
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
N Bissessor, H White - Vascular health and risk management, 2007 - Taylor & Francis
… role of valsartan in left ventricular dysfunction post myocardial … ACE inhibitor use post
myocardial infarction is associated … effective in patients with heart failure post myocardial …
myocardial infarction is associated … effective in patients with heart failure post myocardial …
Valsartan: a review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction
KF Croom, GM Keating - American Journal of Cardiovascular Drugs, 2004 - Springer
… has led to advances in the treatment of these disorders.[1–3] For … in patients who develop
heart failure or left ventricular systolic dysfunction (LVSD) in the post-myocardial infarction (MI) …
heart failure or left ventricular systolic dysfunction (LVSD) in the post-myocardial infarction (MI) …
Post-myocardial infarction heart failure
… use of high-dose beta-blocker appears harmful for patients who present in HF. The American
College of Cardiology (ACC)/American Heart … Therefore, valsartan, in the dosages used in …
College of Cardiology (ACC)/American Heart … Therefore, valsartan, in the dosages used in …
The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
K Park, YD Kim, KS Kim, SH Lee, TH Park… - … Heart Failure, 2018 - Wiley Online Library
… treatment with the maximal tolerated dose of valsartan did not exhibit a superior effect on
post-MI LV remodelling compared with low-dose treatment … this study is the use of beta-blockers …
post-MI LV remodelling compared with low-dose treatment … this study is the use of beta-blockers …
Established and emerging pharmacological therapies for post-myocardial infarction patients with heart failure: a review of the evidence
L De Luca - Cardiovascular Drugs and Therapy, 2020 - Springer
… recommend the use of neurohormonal blocking agents in HF patients [2, 3] … VALsartan In
Acute myocardial iNfarcTion (VALIANT) trial that evaluated the effects of captopril and valsartan…
Acute myocardial iNfarcTion (VALIANT) trial that evaluated the effects of captopril and valsartan…
Valsartan and coronary haemodynamics in early post‐myocardial infarction in rats
M Gervais, C Richer, P Fornes… - Fundamental & …, 1999 - Wiley Online Library
… Valsartan was used at two doses. 5 and 50 mg/kg. which induced a strong and dose-… model
of heart failure, valsartan administered for a short period antagonized cardiac hypertrophy …
of heart failure, valsartan administered for a short period antagonized cardiac hypertrophy …
Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: insight …
M Schou, B Claggett, ZM Miao… - … of Heart Failure, 2023 - Wiley Online Library
… of the patients to either ramipril or sacubitril/valsartan our … and sacubitril valsartan in relation
to use of MRA Patients were … these patients were as expected at higher risk than patients not …
to use of MRA Patients were … these patients were as expected at higher risk than patients not …
Valsartan in the treatment of heart attack survivors
BI Jugdutt - Vascular Health and Risk Management, 2006 - Taylor & Francis
… The overall findings of Val-HeFT support the use of valsartan as an alternative in heart
failure patients intolerant to ACE inhibitors, but not as an add-on to ACE inhibitor therapy. …
failure patients intolerant to ACE inhibitors, but not as an add-on to ACE inhibitor therapy. …
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design
MA Pfeffer, J McMurray, A Leizorovicz, AP Maggioni… - American heart …, 2000 - Elsevier
… rate with either use of valsartan compared with captopril. The … signs of heart failure and/or
evidence of left ventricular systolic … in patients with post–myocardial infarction left ventricular …
evidence of left ventricular systolic … in patients with post–myocardial infarction left ventricular …